These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 11893824)
1. Plasma levels of brain natriuretic peptide increase in patients with idiopathic bilateral atrial dilatation. Arima M; Kanoh T; Kawano Y; Oigawa T; Yamagami S; Matsuda S Cardiology; 2002; 97(1):12-7. PubMed ID: 11893824 [TBL] [Abstract][Full Text] [Related]
2. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation. Wozakowska-Kapłon B; Opolski G Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231 [TBL] [Abstract][Full Text] [Related]
3. Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation. Engelmann MD; Niemann L; Kanstrup IL; Skagen K; Godtfredsen J Int J Cardiol; 2005 Oct; 105(1):31-9. PubMed ID: 16207542 [TBL] [Abstract][Full Text] [Related]
4. The effects of left ventricular diastolic function on natriuretic peptide levels after cardioversion of atrial fibrillation. Bakowski D; Wozakowska-Kapłon B; Opolski G Kardiol Pol; 2009 Apr; 67(4):361-7. PubMed ID: 19492248 [TBL] [Abstract][Full Text] [Related]
5. [Plasma cardiac natriuretic peptide as a biological marker of recurrence of atrial fibrillation in elderly people]. Mabuchi N; Tsutamoto T; Maeda K; Masahiko K Nihon Ronen Igakkai Zasshi; 2000 Jul; 37(7):535-40. PubMed ID: 11031826 [TBL] [Abstract][Full Text] [Related]
6. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters. Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342 [TBL] [Abstract][Full Text] [Related]
7. Plasma atrial natriuretic Peptide and brain natriuretic Peptide levels after radiofrequency catheter ablation of atrial fibrillation. Yamada T; Murakami Y; Okada T; Okamoto M; Shimizu T; Toyama J; Yoshida Y; Tsuboi N; Ito T; Muto M; Kondo T; Inden Y; Hirai M; Murohara T Am J Cardiol; 2006 Jun; 97(12):1741-4. PubMed ID: 16765125 [TBL] [Abstract][Full Text] [Related]
8. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. Ellinor PT; Low AF; Patton KK; Shea MA; Macrae CA J Am Coll Cardiol; 2005 Jan; 45(1):82-6. PubMed ID: 15629379 [TBL] [Abstract][Full Text] [Related]
9. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure]. Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578 [TBL] [Abstract][Full Text] [Related]
11. No correlation between atrial natriuretic peptide concentrations and echocardiographic measurements of left atrial size or left ventricular size and function in patients with persistent atrial fibrillation. Wozakowska-Kaplon B; Opolski G Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S110-4. PubMed ID: 15683475 [TBL] [Abstract][Full Text] [Related]
12. ANP and BNP in atrial fibrillation before and after cardioversion--and their relationship to cardiac volume and function. Therkelsen SK; Groenning BA; Kjaer A; Svendsen JH; Boje Jensen G Int J Cardiol; 2008 Jul; 127(3):396-9. PubMed ID: 17628724 [TBL] [Abstract][Full Text] [Related]
13. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers. Gwechenberger M; Huelsmann M; Graf S; Berger R; Bonderman D; Stanek B; Rauscha F; Pacher R Eur J Clin Invest; 2004 Dec; 34(12):811-7. PubMed ID: 15606723 [TBL] [Abstract][Full Text] [Related]
14. Optimal noninvasive assessment of diastolic heart failure in patients with atrial fibrillation: comparison of tissue doppler echocardiography, left atrium size, and brain natriuretic peptide. Watanabe T; Iwai-Takano M; Oikawa M; Yamaki T; Yaoita H; Maruyama Y J Am Soc Echocardiogr; 2008 Jun; 21(6):689-96. PubMed ID: 17904810 [TBL] [Abstract][Full Text] [Related]
15. Left atrial size by planimetry is superior to M-mode diameter: biochemical calibration by atrial and brain natriuretic peptide. Buchner S; Muscholl M; Debl K; Hense HW; Döring A; Stritzke J; Schunkert H; Jougasaki M; Burnett JC; Riegger GA; Luchner A J Am Soc Echocardiogr; 2008 Apr; 21(4):380-5. PubMed ID: 17681726 [TBL] [Abstract][Full Text] [Related]
16. Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure. Mabuchi N; Tsutamoto T; Maeda K; Kinoshita M Jpn Circ J; 2000 Oct; 64(10):765-71. PubMed ID: 11059617 [TBL] [Abstract][Full Text] [Related]
17. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. Rossi A; Enriquez-Sarano M; Burnett JC; Lerman A; Abel MD; Seward JB J Am Coll Cardiol; 2000 Apr; 35(5):1256-62. PubMed ID: 10758968 [TBL] [Abstract][Full Text] [Related]
18. Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease. Tripepi G; Mattace-Raso F; Mallamaci F; Benedetto FA; Witteman J; Malatino L; Zoccali C Hypertension; 2009 Oct; 54(4):818-24. PubMed ID: 19635983 [TBL] [Abstract][Full Text] [Related]
19. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. Inoue S; Murakami Y; Sano K; Katoh H; Shimada T J Card Fail; 2000 Jun; 6(2):92-6. PubMed ID: 10908082 [TBL] [Abstract][Full Text] [Related]
20. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels. Nakajima K; Onishi K; Dohi K; Tanabe M; Kurita T; Yamanaka T; Ito M; Isaka N; Nobori T; Nakano T Int J Cardiol; 2005 Oct; 104(3):332-7. PubMed ID: 16186065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]